Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Hultman

Plastic and Reconstructive Surgery Raleigh, NC Medical Doctor

NPI 1245324243 CMS profile 237576

3024 New Bern Ave, Raleigh, NC 27610

Open in the dashboard

General payments

$70,497

128 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charles Hultman of Raleigh, NC is reported in the CMS Open Payments database as having received $70,497 across 128 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,582 28
2024 General $5,683 35
2023 General $35,778 29
2022 General $23,348 25
2021 General $3,410 4
2020 General $398 4
2019 General $299 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Hultman
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Charles Hultman were reported at $1,582. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Charles Hultman Plastic and Reconstructive Surgery median Middle half National median
2019 $299 $335 $121–$1,264 $163
2020 $398 $162 $57–$417 $114
2021 $3,410 $245 $89–$735 $132
2022 $23,348 $325 $120–$932 $149
2023 $35,778 $343 $129–$999 $160
2024 $5,683 $390 $141–$1,085 $164
2025 $1,582 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Avita Medical Americas, LLC $39,705 26 payments
  2. Vericel Corporation $24,521 7 payments
  3. Kerecis Limited $1,016 5 payments
  4. AbbVie, Inc. $792 14 payments
  5. Smith+Nephew, Inc. $777 15 payments
  6. TELA Bio, Inc. $670 7 payments
  7. Allergan Inc. $481 7 payments
  8. Integra LifeSciences Corporation $470 9 payments
  9. LifeNet Health $365 5 payments
  10. PolyMedics Innovations Inc $326 4 payments
  11. Other $1,373 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $37,525 7 payments
  2. Grant $15,889 2 payments
  3. Food and Beverage $7,571 108 payments
  4. Honoraria $4,250 3 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $4,000 1 payment
  6. Travel and Lodging $1,262 7 payments
Products named General payments · program years 2019–2025
  1. RECELL Dermatology $32,125 4 payments
  2. EPICEL (CULTURED EPIDERMAL AUTOGRAFTS) $21,221 6 payments
  3. Recell Wound Care $4,360 9 payments
  4. MACI $3,300 1 payment
  5. Recell Plastic Surgery $2,520 6 payments
  6. Kerecis Omega3 SurgiClose $930 4 payments
  7. Kerecis Omega3 GraftGuide $841 3 payments
  8. NATRELLE SALINE-FILLED BREAST IMPLANTS $792 14 payments
  9. Kerecis Omega3 Marigen Wound Care $754 3 payments
  10. Kerecis Omega3 Marigen Wound Care $665 2 payments
  11. Other $9,520 148 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$87,658

Medicare's payments for the services billed

Medicare patients

48

Average age 70

Services billed

508

29 women, 19 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 60%
Depression 52%
Ischemic heart disease 33%
Cancer 33%
Diabetes 29%
Chronic kidney disease 29%
Heart failure 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

128 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record